Table 1 Cochran’s Q test, MR-Egger Intercept and MR-PRESSO of MR analysis for serum 25-Hydroxyvitamin D levels and post-stroke outcome at 3 months
Cochran’s Q Test | MR—Egger | MR-PRESSO | ||||
|---|---|---|---|---|---|---|
Functional Outcome of Stroke (without adjusting for stroke severity) | ||||||
Exposure | Outcome | IVW_Q_P value | Egger_intercept | P value | Global P value | P value |
Serum 25-Hydroxyvitamin D levels | mRS (0–1) VS mRS (2–6) at 3 months | 0.064 | -0.0014 | 0.884 | 0.053 | 0.691 |
Serum 25-Hydroxyvitamin D levels | mRS (0–2) VS mRS (3–6) at 3 months | 0.839 | 0.0061 | 0.468 | 0.851 | 0.051 |
Serum 25-Hydroxyvitamin D levels | mRS at 3 months | 0.292 | -0.0106 | 0.130 | 0.260 | 0.258 |
Functional Outcome of Stroke (adjusting for stroke severity) | ||||||
Exposure | Outcome | IVW_Q_P value | Egger_intercept | P value | Global P value | P value |
Serum 25-Hydroxyvitamin D levels | mRS (0–1) VS mRS (2–6) at 3 months | 0.004 | 0.0093 | 0.255 | 0.004 | 0.782 |
Serum 25-Hydroxyvitamin D levels | mRS (0–2) VS mRS (3–6) at 3 months | 0.639 | 0.0036 | 0.572 | 0.656 | 0.153 |
Serum 25-Hydroxyvitamin D levels | mRS at 3 months | 0.119 | -0.0106 | 0.13 | 0.336 | 0.450 |